News

Concentric by Ginkgo and Illumina collaborate to deploy biosurveillance technologies around the world

The companies plan to join forces to set up pathogen monitoring programs utilizing Illumina technology across Concentric’s global network BOSTON and SAN DIEGO, Jan. 15, 2024 /PRNewswire/ — Concentric by Ginkgo, the biosecurity and public […]

News

Four buyouts (and one rumor that didn’t materialize); Isomorphic Labs’ first pharma deals; A CAR-T IPO; #JPM24 highlights; and more

Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up […]

No Picture
News

Salk Distinguished Professor Emeritus Roger Guillemin, Nobel Prize laureate, celebrates 100th birthday

Roger Guillemin, Salk Distinguished Professor Emeritus and recipient of the 1977 Nobel Prize in Physiology or Medicine, celebrates turning 100 years old on January 11. The post Salk Distinguished Professor Emeritus Roger Guillemin, Nobel Prize […]

News

DNAnexus and Intelliseq Combine Efforts to Add Automated Genomic Variant Interpretation and Clinical Reporting Capabilities to Precision Health Data Cloud

MOUNTAIN VIEW, Calif. & SAN DIEGO–(BUSINESS WIRE)– #ClinicalReport–DNAnexus and Intelliseq announced a partnership to simplify and accelerate variant interpretation and clinical reporting. Click here to view original post

News

Neuralace Medical Announces FDA Clearance of Axon Therapy for Chronic Painful Diabetic Neuropathy

Non-Invasive Magnetic Peripheral Nerve Stimulation (mPNS) Treatment Offers New Hope for PDN Patients SAN DIEGO, Jan. 11, 2024 /PRNewswire/ — Neuralace Medical, Inc., an innovator in pain management technology, today proudly announces the FDA clearance […]

News

#JPM24 quick hits: Ionis on partnership’s pros and cons; Novo Ventures has $600M to spend; Are small molecules back? + more

SAN FRANCISCO — The biopharma extravaganza that is the JP Morgan Healthcare Conference started to wind down Wednesday. Here’s what we’re hearing on Wednesday around San Francisco: Ionis is ready to go solo — After […]

News

Breakthrough Properties Acquires Majority Interest in Callan Ridge, A Newly-Constructed, Fully-Leased Life Science Campus in Torrey Pines

The Acquisition, Via a Strategic Joint Venture with Healthpeak Properties, Further Accelerates Breakthrough’s Growth in Premier Biotech Hubs SAN DIEGO, Calif., Jan. 10, 2024 /PRNewswire/ — Breakthrough Properties (“Breakthrough”), a leading global life sciences real […]

News

Debiopharm and ThinkingNodeLife.ai Forge a Strategic Partnership to Propel Cancer Drug Development with AI Digital Cell Clones

LAUSANNE, Switzerland & SAN DIEGO–(BUSINESS WIRE)–Debiopharm, an independent biopharmaceutical company headquartered in Switzerland, and ThinkingNodeLife.ai (TNL), a trailblazer in AI Digital Cells Lab in USA, are pleased to announce a collaborative partnership aimed at advancing […]

News

Core Biogenesis and Nucleus Biologics Announce Strategic Collaboration for Manufacturing and Distribution of Cost-Effective and Sustainable Recombinant Proteins

SAN DIEGO–(BUSINESS WIRE)– #bioprocessing–In a joint effort to provide lower cost and more defined reagents and media to the cell and gene therapy market, Nucleus Biologics, The Cell Performance Company™, a leading provider of custom […]

News

European Commission Approves KRAZATI (adagrasib) as a Targeted Treatment Option for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) with a KRASG12C Mutation

SAN DIEGO and ZUG, Switzerland, Jan. 10, 2024 /PRNewswire/ — Mirati Therapeutics, Inc.® (NASDAQ: MRTX), a commercial stage biotechnology company, today announced that the European Commission (EC) granted conditional marketing authorization for KRAZATI® (adagrasib) as […]

News

#JPM24: Illumina reports stronger-than-expected growth, indicates Grail divestiture still in early stages

Illumina’s stock rose after reporting stronger quarterly revenue than expected, while company executives during the JP Morgan Healthcare Conference indicated cancer-testing subsidiary Grail won’t be divested imminently. The DNA testing giant reported $1.115 billion in preliminary fourth quarter […]